VanEck Associates’s IperionX IPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48M Sell
1,614,261
-565,828
-26% -$19.3M 0.03% 294
2026
Q1
$56.8M Buy
2,180,089
+842,746
+63% +$35.8M 0.04% 253
2025
Q4
$48.4M Buy
1,337,343
+506,612
+61% +$20.7M 0.04% 249
2025
Q3
$41M Buy
+830,731
New +$33.7M 0.04% 244

Other funds holding IPX

VanEck Associates's IPX Position: Q2 2026 in Review

VanEck Associates reduced its IperionX (IPX) stake by 26% in Q2 2026, selling an estimated $19.3M and leaving 1,614,261 shares worth $48M. The position accounts for 0.03% of the portfolio, ranked #294.

VanEck Associates first reported a position in IPX in Q3 2025 and has held it in 4 quarters since. The position peaked at $56.8M in Q1 2026. 58 funds tracked by Wall St. Rank hold IPX as of Q2 2026.

  • VanEck Associates held 1,614,261 shares of IperionX worth $48M as of Q2 2026.
  • VanEck Associates sold 565,828 IperionX shares in Q2 2026, an estimated $19.3M.
  • IperionX made up 0.03% of VanEck Associates's portfolio in Q2 2026, its #294 holding.
  • VanEck Associates first reported a position in IperionX in Q3 2025 and has held it in 4 quarters since.
  • VanEck Associates's IperionX position peaked at $56.8M in Q1 2026.
  • 58 funds tracked by Wall St. Rank held IperionX as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.